Safety, Tolerability, and Pharmacokinetics of a Single or Multiple Ascending Doses of CPX101
Clinical trial NCT06545162 · COMPLETED
Trial details
- NCT number
- NCT06545162
- Sponsor
- Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-04
- Primary completion
- 2025-12-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.